Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Document Type
Year range
1.
Appl Entomol Zool ; : 1-9, 2022 Oct 09.
Article in English | MEDLINE | ID: covidwho-2244813

ABSTRACT

The red imported fire ant Solenopsis invicta Buren (Hymenoptera: Formicidae) causes serious damage worldwide as an invasive alien species. The species has expanded its range to the Pacific Rim since 2000s and Japan has faced its multiple introductions since 2017. While colony-level control methods are urgently needed, testing living colonies of the unestablished species is challenging especially due to various restrictions under the COVID-19 pandemic. Here, we proposed alternative long-term toxicity assays using artificial colonies of Tetramorium tsushimae Emery (Hymenoptera: Formicidae), a Japanese native species belonging to the same subfamily (Myrmicinae) as S. invicta. We conducted an acute toxicity test to determine if T. tsushimae is a suitable substitute for S. invicta using fipronil and found the LD50 value in T. tsushimae was close to that in S. invicta. Then, we conducted the long-term toxicity test with fipronil and two insect growth regulators (pyriproxyfen and etoxazole) using artificial colonies of T. tsushimae. All workers and larvae in the fipronil-treated colonies died within 3 days of treatment initiation. Emergence of new workers was observed after 18 days in the etoxazole-treated and control colonies, but not in the pyriproxyfen-treated colonies. We concluded that fipronil was the most promising insecticide for post-establishment control, and pyriproxyfen was effective as a toxic-bait agent for colony-level control. Supplementary Information: The online version contains supplementary material available at 10.1007/s13355-022-00800-x.

2.
Epidemiologie et Sante Animale ; 78:1-131, 2020.
Article in French | CAB Abstracts | ID: covidwho-1904311

ABSTRACT

This special issue contains 14 papers from the AEEMA Meeting focusing on the theme entitled "What changes for the management of animals' health crises". Topics of papers include: the management of animals' health crises and introduction to the meeting;evolution of societies perception and social acceptability of sanitary control measures;evolution of the health governance: to adapt the French health system to the new challenge;new challenges for risk management of animal health;evolution of preparedness for the management of animal disease crisis;feedback from the fipronil crisis;towards bovine tuberculosis eradication in Republic of Ireland, including European badgers' vaccination (a review);management of foot-and-mouth disease in Mauritius and Rodrigues: a vaccine strategy for eradication;health and biodiversity during anthropocene;Covid-19 and wild animals;Covid-19 and companion animals;Covid-19 and farmed animals;Covid-19 and laboratory animals;and Preventing SARS-CoV-2 transmission from animals to human beings.

3.
China CDC Wkly ; 4(4): 57-65, 2022 Jan 28.
Article in English | MEDLINE | ID: covidwho-1631490

ABSTRACT

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Effectiveness of China's 2 inactivated vaccines (BBIBP-CorV and CoronaVac) against pre-Delta severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants ranged from 47% to over 90%, depending on the clinical endpoint, and with greater effectiveness against more severe coronavirus disease 2019 (COVID-19). During an outbreak in Guangdong, inactivated vaccine effectiveness (VE) against the Delta variant was 70% for symptomatic infection and 100% for severe COVID-19. However, separate or combined VE estimates for the two inactivated vaccines against Delta are not available. WHAT IS ADDED BY THIS REPORT?: In an outbreak that started in a hospital, VEs of completed primary vaccination with inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the Delta variant were 51%, 61%, and 82%. Completed primary vaccination reduced the risk of progressing from mild to moderate or severe COVID-19 by 74%. VE estimates for BBIBP-CorV and CoronaVac or combined vaccination were similar, and partial vaccination was ineffective. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Completed primary vaccination with either of the 2 inactivated COVID-19 vaccines reduces risk of symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the Delta variant. Completion of the completed primary vaccination with two doses is necessary for protection from Delta.

SELECTION OF CITATIONS
SEARCH DETAIL